Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Effectiveness of KDR2-2 Suspension Eyedrop on Neovascular Regression in the Treatment of Neovascular Glaucoma: an Exploratory Clinical Trial

NCT04844619 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT04844619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04844619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Effectiveness of KDR2-2 Suspension Eyedrop on Neovascular Regression in the Treatment of Neovascular Glaucoma: an Exploratory Clinical Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
April 19, 2021
Completion date
December 31, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular glaucoma, neovascularization